WY-135

CAS: 2163060-83-9

Ref. 3D-NLD06083

Produktinformation

• Name: WY-135
• CAS: 2163060-83-9

Beschreibung

Wy-135 is a potential drug that has shown inhibition of cyclin-dependent kinases. It has been shown to inhibit G1 phase cell cycle progression and induce apoptosis in a dose-dependent manner. Wy-135 has also been shown to inhibit the growth of cancer cells in culture. This compound may be useful as an anti-cancer agent and chemotherapeutic drug. Wy-135 inhibits cellular proliferation and induces apoptosis by inhibiting protein synthesis, DNA replication, and enzyme activity. The cocrystal structure of Wy-135 with cyclin was determined and its inhibitory activities were analyzed by cycle analysis. Wy-135's effects on cancer cells are due to its ability to inhibit the enzymatic activities involved in cell division, including protein synthesis and DNA replication.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 612.1 g/mol
• Formel: C₂₈H₃₄ClN₉O₃S
• Reinheit: Min. 95%